Lihit Lab.,Inc. (TYO:7975)
Japan · Delayed Price · Currency is JPY 1,167.00
-5.00 (-0.43%)
Oct 7, 2026, 3:30 PM JST
Lihit Lab.,Inc. Income Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 9,091 | 9,124 | 9,220 | 8,803 | 8,514 | 8,693 | |
Revenue Growth | -2.49% | -1.04% | 4.74% | 3.39% | -2.06% | 1.51% |
Cost of Revenue | 6,056 | 6,022 | 6,240 | 6,280 | 6,011 | 5,790 |
Gross Profit | 3,035 | 3,102 | 2,980 | 2,523 | 2,503 | 2,903 |
Selling, General & Admin | 2,815 | 2,899 | 2,622 | 2,619 | 2,502 | 2,409 |
Research & Development | 55 | 55 | 63 | 73 | 57 | 51 |
Other Operating Expenses | 7 | 7 | 8 | - | - | - |
Operating Expenses | 2,982 | 3,066 | 2,801 | 2,802 | 2,656 | 2,558 |
Operating Income | 53 | 36 | 179 | -279 | -153 | 345 |
Interest Expense | -4 | -4 | -5 | -4 | -3 | -4 |
Interest & Investment Income | 44 | 44 | 32 | 32 | 26 | 23 |
Currency Exchange Gain (Loss) | 34 | 16 | -4 | 37 | 87 | 28 |
Other Non Operating Income (Expenses) | 3 | 21 | 4 | 4 | 13 | 15 |
EBT Excluding Unusual Items | 130 | 113 | 206 | -210 | -30 | 407 |
Gain (Loss) on Sale of Investments | - | - | 73 | 92 | - | - |
Gain (Loss) on Sale of Assets | 3 | - | 247 | - | - | - |
Asset Writedown | - | -4 | - | - | -1 | -1 |
Other Unusual Items | - | - | 1 | - | - | - |
Pretax Income | 133 | 109 | 527 | -118 | -31 | 406 |
Income Tax Expense | 64 | 42 | 116 | -25 | -7 | 144 |
Net Income | 69 | 67 | 411 | -93 | -24 | 262 |
Net Income to Common | 69 | 67 | 411 | -93 | -24 | 262 |
Net Income Growth | -82.79% | -83.70% | - | - | - | -25.57% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change | -0.00% | -0.03% | - | - | - | 0.03% |
EPS (Basic) | 20.34 | 19.75 | 121.13 | -27.41 | -7.07 | 77.22 |
EPS (Diluted) | 20.34 | 19.75 | 121.13 | -27.41 | -7.07 | 77.22 |
EPS Growth | -82.79% | -83.69% | - | - | - | -25.59% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Free Cash Flow | 159 | -1,366 | 17 | -175 | -824 | 616 |
Free Cash Flow Per Share | 46.87 | -402.71 | 5.01 | -51.58 | -242.85 | 181.55 |
Dividend Per Share | 25.000 | 25.000 | 25.000 | 25.000 | 25.000 | 25.000 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 33.38% | 34.00% | 32.32% | 28.66% | 29.40% | 33.40% |
Operating Margin | 0.58% | 0.40% | 1.94% | -3.17% | -1.80% | 3.97% |
Profit Margin | 0.76% | 0.73% | 4.46% | -1.06% | -0.28% | 3.01% |
Free Cash Flow Margin | 1.75% | -14.97% | 0.18% | -1.99% | -9.68% | 7.09% |
EBITDA | 331 | 306 | 466 | 10 | 137 | 658 |
EBITDA Margin | 3.64% | 3.35% | 5.05% | 0.11% | 1.61% | 7.57% |
D&A For EBITDA | 278 | 270 | 287 | 289 | 290 | 313 |
EBIT | 53 | 36 | 179 | -279 | -153 | 345 |
EBIT Margin | 0.58% | 0.40% | 1.94% | -3.17% | -1.80% | 3.97% |
Effective Tax Rate | 48.12% | 38.53% | 22.01% | - | - | 35.47% |
Advertising Expenses | - | 164 | 161 | 162 | 153 | 127 |